Display options
Cite
Faridi A, Farahnak A, Golmohammadi T, et al. Triclabendazole (Anthelmintic Drug) Effects on the Excretory- Secretory Proteome of Fasciola hepatica in Two Dimension Electrophoresis Gel. Iran J Parasitol. 2014;9(2):202-8
Faridi, A., Farahnak, A., Golmohammadi, T., Eshraghian, M., Sharifi, Y., & Molaei Rad, M. (2014). Triclabendazole (Anthelmintic Drug) Effects on the Excretory- Secretory Proteome of Fasciola hepatica in Two Dimension Electrophoresis Gel. Iranian journal of parasitology, 9(2), 202-8.
Faridi, Ashkan, et al. "Triclabendazole (Anthelmintic Drug) Effects on the Excretory- Secretory Proteome of Fasciola hepatica in Two Dimension Electrophoresis Gel." Iranian journal of parasitology vol. 9,2 (2014): 202-8.
Faridi A, Farahnak A, Golmohammadi T, Eshraghian M, Sharifi Y, Molaei Rad M. Triclabendazole (Anthelmintic Drug) Effects on the Excretory- Secretory Proteome of Fasciola hepatica in Two Dimension Electrophoresis Gel. Iran J Parasitol. 2014 Apr-Jun;9(2):202-8. PMID: 25848386; PMCID: PMC4386040.
Copy Download .nbib Format: NLM
Share it on

Iran J Parasitol. 2014 Apr-Jun;9(2):202-8.

Triclabendazole (Anthelmintic Drug) Effects on the Excretory- Secretory Proteome of Fasciola hepatica in Two Dimension Electrophoresis Gel.

Iranian journal of parasitology

Ashkan Faridi, Ali Farahnak, Taghi Golmohammadi, Mohammadreza Eshraghian, Yosef Sharifi, Mohammadbagher Molaei Rad

Affiliations

  1. Dept. of Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Iran.
  2. Dept. Of Biochemistry, School of Medicine, Tehran University of Medical Sciences, Iran.
  3. Dept. of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Iran.

PMID: 25848386 PMCID: PMC4386040

Abstract

BACKGROUND: The aim of this study was to evaluate the protein spots of excretory - secretory products of Fasciola hepatica using two dimension electrophoresis method in the presence and absence of triclabendazole drug which can be considered to detect the target protein of the drug.

METHODS: F. hepatica parasites were collected from infected cattle livers, divided in two groups and cultivated in RPMI 1640 medium. First group was treated with triclabendazole (TCBZ) and second group considered as control. The excretory-secretory (ES) products of each group were separated and total protein determined by Bradford method. To provide proteome spots, the ES proteins were precipitated and two dimension electrophoresis (2-DE) gel prepared. Protein amounts of two groups were compared using the statistical t-test and protein spots from 2-DE in test and control groups were also statistically analyzed. The protein spots of gels were identified by using protein database.

RESULTS: The t-test showed a significant increase of total proteins in treated group (P<0.5). The protein spots count in the control group was less than test group however statistically not significant (p>0.05). Cathepsin L- protein (MW 36.7 pH 5.34), 14-3-3 epsilon 2 isoform (MW 28.2 pH 5.36), Cathepsin L1D (MW 36.5 pH 5.8) and Cathepsin L1D (MW 36.6 pH 6.26) were identified in test group.

CONCLUSION: It seems that, these results can be considered to determine the proteins which the drug acts as a target on them.

Keywords: Fasciola hepatica; Triclabendazole Proteome; Two - dimensional electrophoresis (2-DE)

References

  1. PLoS Negl Trop Dis. 2012;6(8):e1720 - PubMed
  2. Biotechniques. 2008 Apr;44(5):697-8, 700 - PubMed
  3. Vet Parasitol. 2010 Sep 20;172(3-4):238-48 - PubMed
  4. Proteomics. 2001 Sep;1(9):1128-32 - PubMed
  5. Ann Trop Med Parasitol. 2008 Jun;102(4):283-95 - PubMed
  6. Mol Biochem Parasitol. 2008 Sep;161(1):63-6 - PubMed
  7. Parasitology. 1994 Jun;108 ( Pt 5):555-67 - PubMed
  8. Parasitol Res. 2004 Sep;94(1):61-9 - PubMed
  9. Mol Cell Proteomics. 2007 Jun;6(6):963-72 - PubMed

Publication Types